ADLM Annual Scientific Meeting &amp; Clinical Lab Expo

Our latest innovations

...

Featured solutions

CCM Vertical

Designed for overhead sample transportation, enabling cross walkways, floor to floor transportation, split solutions across different work areas.

cobas^® pro integrated solutions

Scalable and modular solution for your mid- to high-volume clinical chemistry and immunochemistry testing needs, and equipped with innovations that simplify lab operations and enhance faster access to clinical data.

Elecsys^® Alzheimer's CSF Assays

In patients 55 years or older, the CSF assays can efficiently detect amyloid pathology, opening access to new Alzheimer’s therapies.

cobas^® eplex system

Sample-to-answer solution that streamlines the diagnostic workflow from your order entry to the release of the final report.

LightCycler^® PRO System

A qPCR system designed to deliver accuracy and flexibility to research and clinical diagnostic laboratories.

cobas^® 5800 System

A compact, fully automated molecular system that balances a broad menu and testing efficiency with flexible workflows and ease-of-use.

cobas^® prime pre-analytical system

Streamline and simplify your lab operation so technicians can focus on higher-level challenges and opportunities.

cobas^® liat Total Solution

cobas® liat system with cobas® infinity edge smart and navify® infinity POC.

navify® Diagnostics portfolio

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

navify^® Diagnostics portfolio

Building an intelligent lab: Supporting your journey to digitally transform your lab.

Coming Soon: cobas® Mass Spec¹

The cobas® Mass Spec solution is a total end-to-end solution for clinical mass spectrometry testing with the goal of seamless integration into the routine laboratory.

Coming Soon: cobas® c 703 and ISE neo¹

Continued development and enhancement of the cobas® pro integrated solutions analyzer is designed to simplify and optimize high-volume lab operations.

cobas® pure integrated solutions

The cobas® pure supports clinical chemistry and immunochemistry for small to mid-volume laboratories on a footprint of ~21 square feet.

Coming Soon: cobas® pulse

cobas® pulse is an app-based, user-friendly blood glucose management solution that provides a gateway to the future of digital health at the point-of-care.

References

cobas® Mass Spec, cobas® c 703 and ISE neo are in development and not available for sale or distribution in the US.

Would you like to receive updates on Roche at ADLM?

Roche Idea Lab 2024

Roche will present eight Roche Idea Lab segments in the booth, in which experts will discuss topics such as mass spectrometry, digital solutions, point of care, respiratory and STI testing, and the use of high-medical-value assays when treating Alzheimer’s disease, heart failure, and preeclampsia.

Here's are the details for this year's topics.

Tuesday, July 30, 2024

Improving Access and Patient Outcomes for Sexually Transmitted Infections

This session will delve into innovative strategies for enhancing patient access to STI testing and shed light on the promising potential of these approaches to positively impact public health outcomes

Speakers: Barbara Van Der Pol, Ph.D., MPH, University of Alabama at Birmingham, and Casey Pinto, Ph.D., NP, Penn State University

Date/Time: Tuesday, July 30, 11 a.m. CST

Moving Beyond the Transactional Operation with navify® Digital Solutions to Unlock New Possibilities for Better Care

This session will explore how navify® cutting-edge algorithms help move beyond transactional operations to foster a holistic approach for better care with AI.

Speaker: Peter McCaffrey, M.D., University of Texas

Date/Time: Tuesday, July 30, 2:30 p.m. CST

Testing for Heart Failure in People with Diabetes — What Do the New ADA Guidelines Mean for Labs?

This session will discuss how to put the American Diabetes Association recommendation for heart failure risk monitoring in all people with diabetes into practice.

Speaker: Ibrahim A. Hashim, M.Sc., Ph.D., C.Sci., FIBMS, DABCC, FAACC, UT Southwestern Medical Center

Date/Time: Tuesday, July 30, 3:30 p.m. CST

Wednesday, July 31, 2024

Advancing Respiratory Testing Across the Continuum of Care

This session will discuss how strategies to improve diagnostic stewardship for respiratory infections contribute to better patient care.

Speakers: David C. Gaston, M.D., Ph.D., and Alisha Ezell, MHA, MLS(ASCP)^CM, Vanderbilt Health

Date/Time: Wednesday, July 31, 10:30 a.m. CST

Making Patient Impact with Ions: A Conversation on the Medical Value of Mass Spectrometry

This session will feature a conversation on the medical value of mass spectrometry and provide specific case examples related to patient outcomes.

Speaker: Victoria Zhang, Ph.D., MBA, DABCC, University of Rochester Medical Center

Date/Time: Wednesday, July 31, 1 p.m. CST

The Pathway to Growing Your Lab

This session will share ideas on how labs can remain competitive by utilizing existing capacity and improving access for patients in support of optimized clinical care.

Speakers: Steve Serota and Robin Herbner, Wisconsin Diagnostic Laboratories

Date/Time: Wednesday, July 31, 2:30 p.m. CST

Are You Listening? The Black Pregnant Woman's Instincts and Preeclampsia

This session will discuss the Black woman's experience with healthcare and the role diagnostics can play in improving outcomes for preeclampsia patients.

Speaker: Sarosh Rana, M.D., MPH, FACOG, University of Chicago Medicine

Date/Time: Wednesday, July 31, 3:30 p.m. CST

Current and Future Biomarker Testing Landscape in Alzheimer's Disease

This session will discuss how the availability of Alzheimer's biomarkers in CSF and blood is revolutionizing the diagnostic path.

Speaker: Leslie M. Shaw, Ph.D., University of Pennsylvania Perelman School of Medicine

Date/Time: Wednesday, July 31, 4:15 p.m. CST

Would you like to receive updates on Roche at ADLM?

Industry Workshops 2024

Roche will present two medical industry workshops hosted by Roche's Medical and Scientific Affairs team, featuring experts in the fields of artificial intelligence, infectious diseases and Alzheimer's disease. Please see the workshop details below.

Laboratorians' Perspectives on Evaluation and Implementation of Alzheimer's CSF Assays

Early detection of Alzheimer’s disease (AD) pathology can occur in vivo using fluid biomarkers and/or Positron emission tomography (PET) imaging. The FDA approved/cleared cerebrospinal fluid (CSF) ratios can detect AD amyloid pathology early in the disease and correlate with amyloid PET. With the availability of amyloid removal therapies which slow down cognitive decline, it is expected that laboratories will be faced with increased requests for AD testing. A panel of laboratory experts will discuss particularities of evaluation and implementation of AD CSF biomarkers in clinical laboratories.

Speakers: Nam Tran, Ph.D., M.S., HCLD (ABB), CLS, MLS (ASCP)^cm, FAACC; Heather Nelson, Ph.D., DABCC; Christopher Farnsworth, Ph.D.

Date/Time: Tuesday, July 30, 11:30 a.m. CST, in Theater 1

Making a Subjective Sepsis Diagnosis More Objective: The Role of AI-based Sepsis Medical Algorithms in Empowering Healthcare Decisions

Sepsis, a leading cause of death and the costliest condition to treat in U.S. hospitals, poses a significant diagnostic challenge due to patient variability despite efforts to automate its detection. Current methods rely on clinical data or biomarkers, but artificial intelligence (AI) offers a transformative solution. With its profound impact on healthcare, AI is revolutionizing diagnostics, drug discovery, personalized medicine, and patient care. Join us for a session that explores how EMR-Integrated AI digital diagnostics utilizing patient parameters and biomarkers can reshape the diagnosis of sepsis, offering new perspectives and strategies for improved patient outcomes.

Speaker: Bobby Reddy, Jr., CEO, Prenosis, and Kevin M. Klauer, D.O., EJD, FACEP, FACOEP, American Health Information, Management Association

Date/Time: Wednesday, July 31, 11:30 a.m. CST, in Theater 1

Roche Diagnostics Medical & Scientific Affairs will host an open house with educational information and more

What to Expect:

Gain insights into Roche's latest initiatives and strategic priorities.
Engage with experts in various prioritized disease areas.
Explore poster displays staffed by Roche MSA representatives highlighting key potential research areas.
Discover areas of interest for investigator-initiated studies

Enjoy an informal networking session providing ample opportunities to connect with Roche representatives and fellow attendees.

Date: Tuesday, July 30, 2024, 5–7:30 p.m.

Location: Grand Horizon Ballroom A
Marriott Marquis Chicago
2121 South Prairie Avenue, Chicago, IL, 60616

Contact: Kwaku Tawiah, [email protected]

RSVP via this QR code

Would you like to receive updates on Roche at ADLM?